Skip to content
 
Search

Latest Stories

Morrisons launches £129-a-month weight loss injection service

Morrisons introduces weight loss jab subscription

slimming jab Morrisons

The move has sparked criticism on social media

iStock
Gayathri Kallukaran
By Gayathri KallukaranJul 21, 2025
Gayathri Kallukaran
Gayathri Kallukaran is a Junior Journalist with Eastern Eye. She has a Master’s degree in Journalism and Mass Communication from St. Paul’s College, Bengaluru, and brings over five years of experience in content creation, including two years in digital journalism. She covers stories across culture, lifestyle, travel, health, and technology, with a creative yet fact-driven approach to reporting. Known for her sensitivity towards human interest narratives, Gayathri’s storytelling often aims to inform, inspire, and empower. Her journey began as a layout designer and reporter for her college’s daily newsletter, where she also contributed short films and editorial features. Since then, she has worked with platforms like FWD Media, Pepper Content, and Petrons.com, where several of her interviews and features have gained spotlight recognition. Fluent in English, Malayalam, Tamil, and Hindi, she writes in English and Malayalam, continuing to explore inclusive, people-focused storytelling in the digital space.
See Full Bio
Follow:

Highlights

  • Morrisons Clinic introduces subscription service for tirzepatide injections
  • The treatment may aid weight loss of up to 20% over one year
  • Monthly subscription will increase from £129 to £159 after introductory period
  • Service includes medical assessment and regular check-ins
  • Criticism emerges over the supermarket’s continued sale of unhealthy food


Morrisons has launched an online subscription service offering weight loss injections, prompting mixed reactions from the public. The supermarket’s online health platform, Morrisons Clinic, now offers tirzepatide — also known by the brand name Mounjaro — for weight management.

Tirzepatide is primarily prescribed to treat type 2 diabetes, but has also been approved for weight loss. According to Morrisons Clinic, users may lose up to 20 per cent of their body weight over the course of a year.

Cost and treatment details

The service is priced at £129 for the first month, increasing to £159 thereafter. Before beginning treatment, customers are required to complete a medical assessment. Monthly check-ins with a clinical team are part of the subscription, and all prescriptions are handled by trained pharmacists.

“Our expert prescribing pharmacists are specially trained to review, consult and provide medications online,” the website states. “Your healthcare journey is in safe hands.”

The clinic describes its services as being “designed with your long-term health as our priority.”

Backlash over perceived mixed messaging

The move has sparked criticism on social media, with some users accusing the chain of hypocrisy. Critics pointed out that while the supermarket offers medical treatment for weight loss, it also continues to sell ultra-processed, high-fat and high-sugar foods.

One user commented: “It’s genius really. The store sells you unhealthy grub that gets you fat, then wants vast sums of money to get you thin.” Another added: “Is this a parody? One of the culprits, pushing highly processed food, is offering a fat clinic?!”

Morrisons defends online clinic

In response, Morrisons has defended the initiative, stating that its weight loss services are “prescribed and dispensed responsibly.” The clinic offers a range of other health services, including treatments for:

  • Premature ejaculation (£26.99)
  • Acne (£36.99)
  • Acid reflux (£17.99)
  • Erectile dysfunction (£13)
  • Migraines (£15.99)
weight losshealthsocial mediamorrisons

Related News

Dhaka crash
Editorial

At least 20 dead after fighter jet crashes into Dhaka school

Mariah Carey 2025 album
Entertainment

Mariah Carey joins forces with Anderson Paak and L A Reid for first independent album 'Here For It All'

More For You

RSV vaccine premature babies

NHS England says premature babies are three times more likely to be hospitalised due to RSV

iStock

NHS to immunise premature babies against deadly winter virus RSV

Highlights

  • NHS to offer nirsevimab injection to 9,000 premature and high-risk babies from late September
  • Aims to protect against respiratory syncytial virus (RSV), which can cause severe illness in infants
  • Premature babies are 10 times more likely to need intensive care for RSV
  • Nirsevimab offers immediate protection and lasts for six months
  • Neo-natal units across the UK will deliver the jab

Thousands of premature and high-risk babies in the UK will soon be offered a new immunisation to protect against RSV (respiratory syncytial virus), a common winter virus that can cause serious lung infections and hospitalisation. The NHS will begin delivering the nirsevimab injection from late September, aiming to shield vulnerable infants before the colder months set in.

Premature infants at higher risk from RSV

RSV typically causes coughs and colds, but in some children — particularly those born prematurely or with underlying health conditions — it can lead to bronchiolitis, pneumonia, and breathing difficulties. NHS England says premature babies are three times more likely to be hospitalised due to RSV and ten times more likely to require intensive care compared to full-term infants.

Keep ReadingShow less
Donald Trump health 2025

The diagnosis has prompted a wave of public attention

Getty Images

What is chronic venous insufficiency, the condition Donald Trump is diagnosed with?

Highlights

  • President Donald Trump has been diagnosed with chronic venous insufficiency (CVI), a vascular condition affecting blood flow in the legs
  • CVI occurs when leg veins struggle to return blood to the heart, often leading to swelling and discomfort
  • The condition was confirmed following visible leg swelling and bruising
  • Though not life-threatening, CVI can worsen without treatment
  • Trump’s case has sparked public interest in the risks and management of the condition

Trump diagnosed with common but chronic vein condition

President Donald Trump has been diagnosed with chronic venous insufficiency, a condition that affects the proper circulation of blood in the legs. The announcement followed public speculation after Trump was seen with visible swelling in his lower legs and bruising on his hand during recent public appearances.

According to a statement from White House medical staff, tests ruled out more serious cardiovascular conditions. Trump, 79, remains under regular observation, with the condition described as benign and manageable.

Keep ReadingShow less
Babies born free of mitochondrial disease

8 babies have been born in the UK using genetic material from 3 people

iStock

Babies born free of mitochondrial disease using DNA from 3 people

Highlights

  • Eight babies were born in the UK using DNA from three individuals to prevent mitochondrial disease
  • The technique combines egg and sperm from parents with mitochondria from a donor egg
  • Legal in the UK since 2015; results show children are meeting expected milestones
  • One in 5,000 babies are born with mitochondrial disease; no known cure exists
  • Newcastle scientists pioneered the technique, now used under NHS specialist service

UK births mark milestone in preventing inherited mitochondrial disease

Eight babies have been born in the UK using genetic material from three people in a pioneering effort to prevent incurable mitochondrial disease, doctors have confirmed. The technique, developed by researchers in Newcastle, represents a significant breakthrough in reproductive medicine and genetic science.

These births are the first proven cases in the UK of healthy children being born free of devastating mitochondrial disorders thanks to this technique, which has been legal in the country since 2015.

Keep ReadingShow less
Anne-Marie motherhood

Singer Anne-Marie gave an open and emotional interview on BBC Radio 2

Getty Images

‘Everything has changed’: Anne-Marie on motherhood, anxiety and returning to music

Highlights

  • Anne-Marie discussed the challenges of motherhood and returning to work in music
  • Revealed struggles with postnatal anxiety and depression after birth of daughter Seven
  • Praised therapy as a crucial support tool and advised others to seek help
  • Shared insights into life with two young children and how routines have changed her
  • Confirmed she will perform at the Women’s Rugby World Cup opening ceremony on 22 August

Anne-Marie opens up about motherhood and mental health

Singer Anne-Marie gave an open and emotional interview on BBC Radio 2 this morning (16 July), speaking to Scott Mills about the mental and physical challenges she has faced after becoming a mother of two. The artist, known for hits including 2002 and Friends, reflected on the impact of motherhood on her mental health and creative life.

Returning to music while raising a family

Anne-Marie revealed that adjusting to life with two children while returning to the music industry has been “really difficult”. She is mother to daughter Seven, aged one, and a baby son who is just two months old.

Keep ReadingShow less
South Asian fertility

The event follows recent data from the Human Fertilisation and Embryology Authority (HFEA)

iStock

South Asian Heritage Month 2025: Breaking silence on fertility in the community

Highlights:

  • Event part of South Asian Heritage Month, taking place in London
  • Focus on fertility challenges faced by the South Asian community in the UK
  • Speakers include individuals with lived experience and reproductive health experts
  • HFEA data reveals ethnic disparities in IVF outcomes and patient satisfaction
  • Aims to break taboos, encourage open dialogue, and advocate for tailored care

Fertility event aims to spotlight inequalities and cultural stigma

A landmark event during South Asian Heritage Month will explore the unique fertility challenges faced by South Asian communities in the UK. Titled Breaking the Silence – Fertility Journeys in the South Asian Community, the event will take place in London on Tuesday 5 August from 5:30pm to 8:15pm.

The panel gathering will feature individuals with lived experience of infertility, baby loss and involuntary childlessness, alongside clinicians and mental health professionals specialising in reproductive care. The goal is to open up often-silenced conversations and address disparities in access to fertility treatment and patient outcomes among South Asian groups.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Asian Media Group USA Inc